![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Chugai to Jointly Establish Company With Mitsui and CIEA
Chugai to Jointly Establish Company With Mitsui and CIEA
April 20, 2005
Chugai Pharmaceutical announced that "Forerunner Pharma Research Co., Ltd." (FPR) was jointly established with Mitsui & Co., Ltd. and Central Institute for Experimental Animals (CIEA). FPR will be engaged in the discovery of innovative new pharmaceuticals and diagnostic products and is planning to commence operations from April 22, 2005. In 2002, Chugai, Mitsui, and CIEA established a joint venture called PharmaLogicals Research Pte. in Singapore and have been promoting research programs through setting up of new genome-based drug discovery system for the efficient generation of therapeutic antibodies by obtaining pathological and genomic information from disease and genetic analysis.
Belga Press Releases
(http://www.pressreleases.be/script_UK/newsdetail.asp?nDays=w&ID=26321)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct